The Quince Health Policy Analysis and Evidence-based Public Health
Home
CME | Pubwise | The Quince | Undergrad Teaching | Publishing | Personal
Home
Up

 



The Quince ...

 Issue 14

In This Issue

Circumcision - males in Bro Taf
Too much surgery in dying patients
Damn Volvo has its lights on
Randomisation worth the effort?
Randomised Trials improving?
Acute Otitis Media

Circumcision - males in Bro Taf

There has been some media interest in the circumcision of boys by NHS surgeons, making the point that the operation should be rare, but that where it was indicated, it should be performed by a paediatric, not a general surgeon.

This seems to make sense. We decided therefore to look at male circumcision rates in Bro Taf, to see if there was any difference in the way such cases were managed in the four unitary authority, shortly to be Local Health Group areas. Fig.1 shows the rates of circumcision performed on the NHS in Bro Taf last year. It appears that Merthyr has much higher rates that other areas of Bro Taf or the English figure. This needs further investigation.

Back to top


Too much surgery in dying patients

A BMJ article in November reported the National Confidential Inquiry into Perioperative Deaths had the above striking headline. The inquiry team, which collects data on patients who die within 30 days of a surgical procedure, looked at 2541 deaths in detail to see what lessons could be learned for the future. These deaths represented 13% of the 19,496 perioperative deaths reported during the year April 1996 to March 1997.

The message that recurs throughout the report is that surgeons need to be clear about the aims of surgery. "A decision to operate may not be in the best interests of the patient," the report says.

This applies across specialties. In gynaecology, the report says: "Surgery for benign disease can have a poor outcome if the age, physical status of the patient and the type of hysterectomy are not taken into account."

Similarly, the experts feel that percutaneous endoscopic gastrostomy is being performed on too many patients with a very short life expectancy. "A percutaneous endoscopic gastrostomy was performed in situations where symptom control right have been more relevant," it says.

Ref (web)

Back to top


Damn Volvo has its lights on

A recent Bandolier mentions the work going on in Wales, led by Ronan Lyons, to gather evidence on injury prevention strategies and categorised it in terms of the strength of evidence and whether interventions are beneficial or harmful (http: /www.uwcm.ac.uk / uwcm / lib / pep). One item of special interest was the question of the use of running lights on cars in daytime.

All the known studies on the use of daytime running lights were collected in a met-analysis. Some of these were randomised (some cars had lights on, others did not, usually from a fleet of cars), some were before-and-after studies with a comparison group, and some were simple before-and-after studies, for instance when a new law came into force.

The outcome was accidents occurring in daytime between cars, or between cars and pedestrians or cyclists. The effect was about a 15% reduction in accident rates.

The beneficial effects were maintained whether the proportion of cars using lights was 30 or 50% at the start of a study, and from 60% to 95% at the end. The review makes a good case that using daytime running lights right now in the UK should reduce the effect of an accident for an individual car of about 15%.

Ref to Bandolier homepage

Back to top


Randomisation worth the effort?

Those of us who have spent much time attempting to set up randomised controlled trials often wonder if its was worth all the fuss (after all Archie Cochrane did his best work on cohort studies). It is therefore cheering to read in the BMJ back in October that it is.

They reported eighteen studies that compared randomised controlled trials with non-randomised controlled trials or trials that were more adequate in terms of randomisation compared with those which were less adequate.

Failure to use random allocation and concealment of allocation were associated with relative increases in estimates of effects of one treatment or the other of 150% or more. The authors conclude that not using concealed random allocation can distort the apparent effects of care in either direction, causing the effects to seem either larger or smaller than they really are.

Back to top


Randomised Trials improving?

While on the subject of randomised controlled trials (RCTS) the October issue of the BMJ which looked at trials had another fascinating article.

This study examined 2,000 controlled trials on the treatment of schizophrenia over the last 50 years. Most trials are undertaken in North America. The United States, in particular, has a strong tradition of evaluative research but only 2% of the world’s population of people live in North America. How applicable the findings of these trials are to the 43 million other patients in Africa, Australasia, and Europe is difficult to assess.

The quality of reporting in this large sample of trials was poor and showed no sign of improvement over time. As low quality scores are associated with an increased estimate of benefit, schizophrenia trials may well have consistently overestimated the effects of experimental interventions.

Drug treatments are the bulwark of treatment of schizophrenia, so it is not surprising that drug trials dominate the sample. Most important drug trials in recent years use haloperidol as the control. This is likely to be a potent cause of adverse effects so if the new experimental drug has moderate antipsychotic properties, favourable outcomes can be expected. Comparisons with other old, but less toxic, antipsychotic drugs are rare. Further difficulties with using the evidence generated by this mass of research are that the studies are of limited duration for an illness that often lasts decades.

The findings of this survey are as bad, if not worse, as those for other disciplines of health care. There is great scope for well conceived, conducted, and reported trials.

Back to top


Acute Otitis Media

A search sought randomised trials comparing different durations of antibiotic treatment in children with a diagnosis of acute otitis media. Thirty two trials were found and included.

The results showed that long courses of antibiotics confer little, if any, benefit over short courses. The fact that there was a benefit in the trials at 8-16 days is probably more of a reflection of the fact that the long course is only just completed and does not allow for any recurrence in the time.

Back to top

 

Last updated:

Copyright 2003 | Norman Vetter


Send mail to njvetter@hotmail.com with questions or comments